Copyright
©The Author(s) 2024.
World J Diabetes. Sep 15, 2024; 15(9): 1979-2001
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1979
Published online Sep 15, 2024. doi: 10.4239/wjd.v15.i9.1979
Name | Sequence (5’-3’) | |
miR-129-5p | Forward | CGGCGGTTTGCGGTCTGGGCT |
Reverse | CAACTGGAGGACTCCATGCTG | |
U6 | Forward | GATCTCGGAAGCTAAGCAGG |
Reverse | TGGTGCAGGGAGGTAT | |
mouseHMGB1 | Forward | ATCCCAATGCACCCAAGAGG |
Reverse | CAATGGACAGGCCAGGATGT | |
mouseGAPDH | Forward | AGGTCGGTGTGAACGGATTTG |
Reverse | TGTAGACCATGTAGTTGAGGTC | |
mouseIL-6 | Forward | GGCCCTTGCTTTCTCTTCG |
Reverse | ATAATAAAGTTTTGATTATGT | |
mouseTNF-α | Forward | GACCCTCACACTCAGATCATCTTCT |
Reverse | CCTCCACTTGGTGGTTTGCT |
- Citation: Wang YY, Li K, Wang JJ, Hua W, Liu Q, Sun YL, Qi JP, Song YJ. Bone marrow-derived mesenchymal stem cell-derived exosome-loaded miR-129-5p targets high-mobility group box 1 attenuates neurological-impairment after diabetic cerebral hemorrhage. World J Diabetes 2024; 15(9): 1979-2001
- URL: https://www.wjgnet.com/1948-9358/full/v15/i9/1979.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i9.1979